Torrent Pharmaceuticals announced a 20% year-on-year increase in consolidated net profit, reaching Rs 548 crore for the June quarter. This growth was fueled by robust sales across key markets, including India and the US. India revenues surged by 11% to Rs 1,811 crore, while US business revenues rose by 19% to Rs 308 crore. Shares of Torrent Pharma closed 0.